MedPath

Comparison of surfactant injection method in neonates with respiratory distress

Phase 3
Conditions
Respiratory distress syndrome of newborn.
Respiratory distress syndrome of newborn
P22.0
Registration Number
IRCT20201222049802N4
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
84
Inclusion Criteria

Neonates with a gestational age less than or equal to 34 weeks
Neonates who were not intubated at birth
Neonates who are on non-invasive respiratory support at birth
Moderate or severe respiratory distress
FIO2 requirement greater than 40%
need surfactant injection

Exclusion Criteria

Congenital abnormalities
Congenital structural pulmonary disease
Congenital heart disease
neonates who underwent advanced resuscitation at birth
neonates who were intubated due to severe respiratory distress at birth
neonates with a gestational age of less than 26 weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The need for intubation in the first 72 hours of birth. Timepoint: The first 72 hours of birth. Method of measurement: Record patient file information.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath